Corpus ID: 77311678

Placement: Is Our Understanding of Restenosis Changing? Temporal Course of Neointimal Formation After Drug-Eluting Stent

@inproceedings{Finn2009PlacementIO,
  title={Placement: Is Our Understanding of Restenosis Changing? Temporal Course of Neointimal Formation After Drug-Eluting Stent},
  author={A. Finn and G. Nakazawa and F. Kolodgie and R. Virmani},
  year={2009}
}
2009;2;300-302 J. Am. Coll. Cardiol. Intv. Aloke V. Finn, Gaku Nakazawa, Frank D. Kolodgie, and Renu Virmani Placement: Is Our Understanding of Restenosis Changing? Temporal Course of Neointimal Formation After Drug-Eluting Stent This information is current as of April 22, 2009 http://interventions.onlinejacc.org/cgi/content/full/2/4/300 located on the World Wide Web at: The online version of this article, along with updated information and services, is 
1 Citations

Figures and Topics from this paper

References

SHOWING 1-10 OF 14 REFERENCES
Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer.
  • 170
Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
  • 2,575
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing
  • 847
  • PDF
Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent
  • 171
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
  • 4,271
  • PDF
Three-year follow-up after implantation of metallic coronary-artery stents.
  • 514
...
1
2
...